Additionally, pancreatic cancer cell proliferation and tumor growth were highly decreased when PTP1B was inhibited by a specific inhibitor, which supported the notion of PTP1B as a promising therapeutic target for PDAC (Figs. 4 and 5). This evidence concerns the gene PTPN1 and pancreatic neoplasm.